Form 8-K - Current report:
SEC Accession No. 0001127855-14-000475
Filing Date
2014-10-23
Accepted
2014-10-23 15:48:18
Documents
9
Period of Report
2014-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CEL-SCI CORP 8K, 10.21.14 celsci8k102114.htm 8-K 38738
2 CEL-SCI CORP 8K, UNDERWRITING AGREEMENT celsciexh1_1.htm EX-1.01 279811
3 CEL-SCI CORP 8K, TERMS OF WARRANTS celsciexh4.htm EX-4 106316
4 CEL-SCI CORP 8K, LEGAL OPINION celsciexh5.htm EX-5 14296
5 CEL-SCI CORP 8K, WARRANT AGENT AGREEMENT celsciexh10_kk.htm EX-10.KK 327548
6 CEL-SCI CORP 8K, LEGAL CONSENT celsciexh23.htm EX-23 4810
7 CEL-SCI CORP 8K, PRESS RELEASE celsciexh99_1.htm EX-99.1 10051
8 CEL-SCI CORP 8K, PRESS RELEASE celsciexh99_2.htm EX-99.2 9624
9 CEL-SCI CORP 8K, GRAPHIC 1 celsci_logo.jpg GRAPHIC 7555
  Complete submission text file 0001127855-14-000475.txt   803023
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 141169944
SIC: 2836 Biological Products, (No Diagnostic Substances)